J&J Says Vaccine Shows High Efficacy on South African Variant

Mar.01 -- Johnson & Johnson Chief Scientific Officer Paul Stoffels discusses the efficacy of vaccines, testing a two-shot regime of the company’s vaccine, and when vaccinations may be expanded to pregnant women and children. He speaks on "Bloomberg Markets."